Shanxi Deyuantang Pharmaceutical

Shanxi Deyuantang Pharmaceutical Co., Ltd. is a Chinese pharmaceutical manufacturer and developer headquartered in Jinzhong, Shanxi. Established in 2003, the company produces a wide range of products including traditional Chinese medicines (TCM), modern chemical generics, and active pharmaceutical ingredients (APIs). Its core focus areas include endocrinology, metabolic diseases, and cardiovascular health, with a portfolio that features advanced small molecule generics such as Dapagliflozin/Metformin and Azilsartan. The company operates a large-scale GMP-certified manufacturing facility and is involved in bioequivalence studies for high-value generic drugs in the Chinese market.